|
|
Article: TKT to Hold Special Meeting of Stockholders on July 27, 2005.
- Article from:
- PR Newswire
- Article date:
- June 27, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass., June 27 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. today announced its plans to hold a special meeting of the stockholders to approve the proposed acquisition of the company by Shire Pharmaceuticals Group plc. The special meeting of stockholders will be held on Wednesday, July 27, 2005 at the offices of Wilmer Cutler Pickering Hale and Dorr LLP, located at 60 State Street, Boston, Massachusetts at 9:00 a.m. eastern time. A definitive proxy statement has been filed with the SEC and is available at http://www.tktx.com/ within the Investor Information section.
As previously announced on April 21, 2005, TKT and Shire signed a ...